- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Envision Pharma Group appoints new CEO
Envision Pharma Group is pleased to announce the appointment of Meg Heim as its new Chief Executive Officer. Throughout her career she has championed the professionalism of medical affairs and the innovations that improve patient experience.
Meg Heim
Working closely with an experienced Executive Leadership Team, Meg will be responsible for delivering an ambitious five-year plan that will reinforce Envision a the global leader in scientific and commercialization strategy and solutions, medical affairs, and lifecycle planning.
Meg said: “I am energized to be joining Envision Pharma Group at such an important time in the industry. I see a clear opportunity for further growth building off established and new opportunities in the sector. The company has an exceptional team and client base, and I am looking forward to spending time with our people, our clients, and other key partners.”
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
